-- Robert Preidt
THURSDAY, Nov. 3 (HealthDay News) -- Allergy shots are
time-tested treatments that reduce health care costs and can now
provide relief to allergy sufferers within weeks instead of months,
according to experts.
And while allergy shots are currently given under the skin
(subcutaneously), new methods of allergy immunotherapy are being
investigated, delegates heard at this week's annual scientific
meeting of the American College of Allergy, Asthma and Immunology
(ACAAI) in Boston.
Those potential new techniques include:
Accelerated allergy immunotherapy and the cost benefits of
immunotherapy were also discussed at the meeting.
Conventional immunotherapy requires patients to receive an
allergy shot once or twice a week for about five months. But "rush"
and "cluster" immunotherapy methods feature accelerated schedules
to shorten that treatment period.
Rush immunotherapy typically involves giving multiple injections
to a patient two or three days in a row, but schedules may be
shorter or longer based on circumstances. Cluster immunotherapy
involves two to four injections, given 30 minutes apart, one day a
week for three weeks.
"You shouldn't have to put your life on hold to treat your allergies," Dr. Richard Weber, ACAAI vice president, said in a college news release. "Accelerated schedules offer patients more flexibility, faster results and a treatment plan they are more likely to follow because it reflects their needs and busy lifestyle."
"Research shows accelerated schedules are safe and effective options, and they appeal to patients who do not want to commit to weekly allergy shots for five or six months," he added.
Not only is allergy immunotherapy highly effective, it can save
thousands of dollars in health care costs per patient, according to
a study presented at the meeting.
Researchers examined Florida Medicaid data and found that
children with allergies who received allergy immunotherapy had
nearly $6,000 less in health care costs over 18 months than
children with allergies who did not receive allergy immunotherapy.
Among adults, the amount saved over 18 months was more than
Because this research was presented at a medical meeting, the
data and conclusions should be viewed as preliminary until
published in a peer-reviewed journal.
"Allergy immunotherapy is a well-established, safe and effective treatment. Our research clearly shows that this treatment is also cost effective and these cost benefits occur almost immediately," Cheryl Hankin, president and chief scientific officer of BioMedEcon, said in the news release.
The American Academy of Family Physicians has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.